Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-13 · accession 0000882796-25-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | 2025-11-13 | BCRX | SANDERS MACHELLE | Dir | S - Sale | $7.14 | -9,600 | 30.6K | -24% | -$68.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | S | D | 9,600 | $7.14 | 30,642 | D | — | — | (F1) These shares were sold pursuant to a plan adopted by the Reporting Person on August 14, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person. |